Brief: 4D Molecular Therapeutics Q3 Net Income USD -56.876 Million Vs. IBES Estimate USD -56.2 Million
10/11/2025 13:00
Nov 10 (Reuters) - 4D Molecular Therapeutics Q3 basic EPS USD -1.01. Q3 operating income USD -61.185 million vs. IBES estimate USD -61.6 million Q3 revenue USD 90 thousand vs. IBES estimate USD 287.9 thousand Q3 operating expenses USD 61.275 million
Recent news on 4D Molecular Therapeutics
See all news4D Molecular Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
4D Molecular Therapeutics Q2 net loss widens
Brief: 4D Molecular Therapeutics Q2 Net Income USD -72.936 Million Vs. IBES Estimate USD -70.3 Million
4D Molecular Therapeutics Inc expected to post a loss of $1.02 a share - Earnings Preview
Brief: 4d Molecular Therapeutics Says 4D-150 Continues To Be Well Tolerated With No New Safety Findings